Fierce Pharma interview - ixlayer

November 17, 2024

Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2024 for a quick interview about the current and future state of pharma marketing.

More Posts

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma

Header

Key Takeaways from Exploring Best Practices for Biopharma DTP Implementation – Part 2

Key Takeaways from Exploring Best Practices for Biopharma DTP Implementation – Part 2 ixlayer’s recent webinar in collaboration with The DHC Group, Exploring Best Practices for Biopharma DTP Implementation, clarifies

Key Takeaways from Exploring Best Practices for Biopharma DTP Implementation – Part 1

Key Takeaways from Exploring Best Practices for Biopharma DTP Implementation – Part 1 ixlayer’s recent webinar in collaboration with The DHC Group, Exploring Best Practices for Biopharma DTP Implementation, clarifies

ixlayer is Recognized as a Premiere Patient Engagement Startup and Named to the 2025 New York Digital Health 100

ixlayer is Recognized as a Premiere Patient Engagement Startup and Named to the 2025 New York Digital Health 100 ixlayer is a top 100 healthcare company powering direct-to-patient platforms for

One Platform,
Built for Biopharma.

©IX Layer Inc. 2025
All Rights Reserved

Services

The Company

Get In Touch

Corporate Office - West Coast

IX Layer Inc.
447 Sutter Street, Suite 405, PMB 53
San Francisco, CA 94108

Corporate Office - East Coast

IX Layer Inc.
222 Broadway, 22nd Floor
New York, NY 10038

Consent Preferences